Member access

4-Traders Homepage  >  Shares  >  Nyse MKT  >  CEL-SCI Corporation    CVM   US1508375086

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

CEL SCI : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)

03/18/2015 | 03:33pm US/Eastern

Item 5.03 Amendments to Articles of Incorporation or Bylaws, Change in

            Fiscal Year End.

On March 16, 2015, CEL-SCI's directors amended Article II, Section 4 of the Company's bylaws (attached as Exhibit 3(ii)).

Item 9.01   Exhibits

Exhibit
Number      Description of Document
------      -----------------------

  3(ii)     Amendment to Article II, Section 4 of the bylaws





                                       2

© Edgar Online, source Glimpses

React to this article
Latest news on CEL-SCI CORPORATION
03/18 CEL SCI : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form ..
03/12 CEL-SCI CORPORATION : Cel-Sci's Cancer Immunotherapy In Phase III Is Value Oppor..
03/09 CEL SCI : Secures Clearance to Conduct Phase III Trial in 21 Countries
03/06 CEL SCI : Updates on Patient Enrollment in 2015 for Its Phase III Head and Neck ..
03/04 CEL SCI : FinancialBuzz.com Exclusive Interview With CEL-SCI CEO Geert Kersten F..
03/04 CEL SCI : CEO Geert Kersten Interviewed by The Life Sciences Report
03/04 CEL SCI : Gets Clearance to Conduct Phase III Trial in 21 Countries
03/03 CEL SCI : NEW STORY CEL-SCI Completes Key Milestone with Clearance to Conduct Ph..
03/03 CEL SCI : NEW STORY CEL-SCI Reports 2nd Consecutive Month of Record Patient Enro..
03/03 CEL SCI : Reports 2nd Consecutive Month of Record Patient Enrollment in 2015 for..
Advertisement
Chart
Duration : Period :
CEL-SCI Corporation Technical Analysis Chart | CVM | US1508375086 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF